Latest filing published 20 Oct 2020 for Tarsus Pharmaceuticals, Inc., €2.3M.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +12.4%Entry US$24.50 · Close at T+365 US$27.53
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Horowitz Limited Partnership VIII: trading record in brief
All filings by Horowitz Limited Partnership VIII on record concern Tarsus Pharmaceuticals, Inc. In total, 7 filings cover trades dated 20 October 2020.
On the market, this insider has only ever bought: 2 purchases, €2.5M in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The record was last updated on 20 October 2020 with an open-market purchase (€2.3M) in Tarsus Pharmaceuticals, Inc. Half of the filings or more reach the SEC (Form 4) feed on the day of the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Horowitz Limited Partnership VIII
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 168,750 shares@ US$16.0091.5% of flowCommon StockSEC:0001209191-20-055424:3Canonical exit: 18 Jan 2021 (T+90)
- 15,625 shares@ US$16.008.5% of flowCommon StockSEC:0001209191-20-055424:6Canonical exit: 18 Jan 2021 (T+90)
- 1,434,790 sharesCommon StockSEC:0001209191-20-055424:0
- 245,966 sharesCommon StockSEC:0001209191-20-055424:1
- 71,427 sharesCommon StockSEC:0001209191-20-055424:2
- 43,151 sharesCommon StockSEC:0001209191-20-055424:4
- 7,396 sharesCommon StockSEC:0001209191-20-055424:5
7 of 7 declarations
